These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 3494105

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Regional cerebral glucose metabolism in monozygotic twins discordant for Alzheimer's disease.
    Järvenpää T, Räihä I, Kaprio J, Koskenvuo M, Laine M, Kurki T, Vahlberg T, Viljanen T, Ahonen K, Rinne JO.
    Dement Geriatr Cogn Disord; 2003; 16(4):245-52. PubMed ID: 14512720
    [Abstract] [Full Text] [Related]

  • 3. Cerebral glucose metabolism in dizygotic twin pairs discordant for Alzheimer's disease.
    Virta JJ, Karrasch M, Kaprio J, Koskenvuo M, Räihä I, Viljanen T, Rinne JO.
    Dement Geriatr Cogn Disord; 2008; 25(1):9-16. PubMed ID: 18025784
    [Abstract] [Full Text] [Related]

  • 4. Clinical, neuroimaging, and environmental risk differences in monozygotic female twins appearing discordant for dementia of the Alzheimer type.
    Small GW, Leuchter AF, Mandelkern MA, La Rue A, Okonek A, Lufkin RB, Jarvik LF, Matsuyama SS, Bondareff W.
    Arch Neurol; 1993 Feb; 50(2):209-19. PubMed ID: 8431141
    [Abstract] [Full Text] [Related]

  • 5. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
    Small GW, Mazziotta JC, Collins MT, Baxter LR, Phelps ME, Mandelkern MA, Kaplan A, La Rue A, Adamson CF, Chang L.
    JAMA; 1993 Feb; 273(12):942-7. PubMed ID: 7884953
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type.
    Mielke R, Herholz K, Grond M, Kessler J, Heiss WD.
    Neurobiol Aging; 1992 Feb; 13(1):93-8. PubMed ID: 1542386
    [Abstract] [Full Text] [Related]

  • 8. Hippocampal MRI volumetry in cognitively discordant monozygotic twin pairs.
    Järvenpää T, Laakso MP, Rossi R, Koskenvuo M, Kaprio J, Räihä I, Kurki T, Laine M, Frisoni GB, Rinne JO.
    J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):116-20. PubMed ID: 14707319
    [Abstract] [Full Text] [Related]

  • 9. Cerebral metabolic and cognitive studies in dementia with frontal lobe behavioral features.
    Kumar A, Schapiro MB, Haxby JV, Grady CL, Friedland RP.
    J Psychiatr Res; 1990 Jan; 24(2):97-109. PubMed ID: 2213642
    [Abstract] [Full Text] [Related]

  • 10. Anatomic, metabolic, neuropsychological, and molecular genetic studies of three pairs of identical twins discordant for dementia of the Alzheimer's type.
    Kumar A, Schapiro MB, Grady CL, Matocha MF, Haxby JV, Moore AM, Luxenberg JS, St George-Hyslop PH, Robinette CD, Ball MJ.
    Arch Neurol; 1991 Feb; 48(2):160-8. PubMed ID: 1993007
    [Abstract] [Full Text] [Related]

  • 11. Voxel-based analysis of cerebral glucose metabolism in mono- and dizygotic twins discordant for Alzheimer disease.
    Virta JJ, Aalto S, Järvenpää T, Karrasch M, Kaprio J, Koskenvuo M, Räihä I, Viljanen T, Rinne JO.
    J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):259-66. PubMed ID: 18977818
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A 90-year-old monozygotic female twin pair discordant for Alzheimer's disease.
    Järvenpää T, Räihä I, Kaprio J, Koskenvuo M, Laine M, Kurki T, Viljanen T, Rinne JO.
    Neurobiol Aging; 2003 Nov; 24(7):941-5. PubMed ID: 12928054
    [Abstract] [Full Text] [Related]

  • 14. Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function.
    Yoshida K, Ogasawara K, Saura H, Saito H, Kobayashi M, Yoshida K, Terasaki K, Fujiwara S, Ogawa A.
    J Neurosurg; 2015 Dec; 123(6):1546-54. PubMed ID: 26230467
    [Abstract] [Full Text] [Related]

  • 15. High-resolution PET studies in Alzheimer's disease.
    Kumar A, Schapiro MB, Grady C, Haxby JV, Wagner E, Salerno JA, Friedland RP, Rapoport SI.
    Neuropsychopharmacology; 1991 Jan; 4(1):35-46. PubMed ID: 2003867
    [Abstract] [Full Text] [Related]

  • 16. Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndrome.
    Cutler NR.
    Prog Neuropsychopharmacol Biol Psychiatry; 1986 Jan; 10(3-5):309-21. PubMed ID: 2948218
    [Abstract] [Full Text] [Related]

  • 17. [Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].
    Okada J, Peppard R, Calne DB.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May 25; 49(5):643-56. PubMed ID: 2798056
    [Abstract] [Full Text] [Related]

  • 18. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.
    Am J Psychiatry; 2002 May 25; 159(5):738-45. PubMed ID: 11986126
    [Abstract] [Full Text] [Related]

  • 19. Association of elevated phospho-tau levels with Alzheimer-typical 18F-fluoro-2-deoxy-D-glucose positron emission tomography findings in patients with mild cognitive impairment.
    Fellgiebel A, Siessmeier T, Scheurich A, Winterer G, Bartenstein P, Schmidt LG, Müller MJ.
    Biol Psychiatry; 2004 Aug 15; 56(4):279-83. PubMed ID: 15312816
    [Abstract] [Full Text] [Related]

  • 20. Progressive apraxia in clinically discordant monozygotic twins.
    Caselli RJ, Reiman EM, Timmann D, Stelmach GE, Lawson MA, Osborne D, Moore SB, Cevette MJ.
    Arch Neurol; 1995 Oct 15; 52(10):1004-10. PubMed ID: 7575217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.